The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
An update on the management of urinary tract infections in the era of antimicrobial resistance
Abstract
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a growing concern due to limited therapeutic options. Gram-negative bacteria, specifically Enterobacteriaceae, are common causes of both community-acquired and hospital acquired UTIs. These organisms can acquire genes that encode for multiple antibiotic resistance mechanisms, including extended-spectrum-lactamases (ESBLs), AmpC- β -lactamase, and carbapenemases. The assessment of suspected UTI includes identification of characteristic symptoms or signs, urinalysis, dipstick or microscopic tests, and urine culture if indicated. UTIs are categorized according to location (upper versus lower urinary tract) and severity (uncomplicated versus complicated). Increasing rates of antibiotic resistance necessitate judicious use of antibiotics through the application of antimicrobial stewardship principles. Knowledge of the common causative pathogens of UTIs including local susceptibility patterns are essential in determining appropriate empiric therapy. The recommended first-line empiric therapies for acute uncomplicated bacterial cystitis in otherwise healthy adult nonpregnant females is a 5-day course of nitrofurantion or a 3-g single dose of fosfomycin tromethamine. Second-line options include fluoroquinolones and β-lactams, such as amoxicillin-clavulanate. Current treatment options for UTIs due to AmpC- β -lactamase-producing organisms include fosfomycin, nitrofurantion, fluoroquinolones, cefepime, piperacillin-tazobactam and carbapenems. In addition, treatment options for UTIs due to ESBLs-producing Enterobacteriaceae include nitrofurantion, fosfomycin, fluoroquinolones, cefoxitin, piperacillin-tazobactam, carbapenems, ceftazidime-avibactam, ceftolozane-tazobactam, and aminoglycosides. Based on identification and susceptibility results, alternatives to carbapenems may be used to treat mild-moderate UTIs caused by ESBL-producing Enterobacteriaceae. Ceftazidime-avibactam, colistin, polymixin B, fosfomycin, aztreonam, aminoglycosides, and tigecycline are treatment options for UTIs caused by carbapenem-resistant Enterobacteriaceae (CRE). Treatment options for UTIs caused by multidrug resistant (MDR)-Pseudomonas spp. include fluoroquinolones, ceftazidime, cefepime, piperacillin-tazobactam, carbapenems, aminoglycosides, colistin, ceftazidime-avibactam, and ceftolozane-tazobactam. The use of fluoroquinolones for empiric treatment of UTIs should be restricted due to increased rates of resistance. Aminoglycosides, colistin, and tigecycline are considered alternatives in the setting of MDR Gram-negative infections in patients with limited therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Hooton, T. M., Bradley, S. F., Cardenas, D. D., Colgan, R., Geerlings, S. E., Rice, J. C., Saint, S., Schaeffer, A. J., Tambayh, P. A., Tenke, P., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650482 · Cited by 2,099
The epidemiology of urinary tract infection
Foxman, B. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.190 · Cited by 1,771
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Urinary Tract Infection Syndromes
Foxman, B. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.09.003 · Cited by 1,333
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Ambulatory Medical Care Utilization Estimates for 2006: (587152010-001)
Schappert, S. M., & Rechtsteiner, E. A. (2008) · PsycEXTRA Dataset · doi:10.1037/e587152010-001 · Cited by 699
Falagas, M. E., Vouloumanou, E. K., Samonis, G., & Vardakas, K. Z. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-15 · Cited by 612
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 603
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit278 · Cited by 592
Does This Woman Have an Acute Uncomplicated Urinary Tract Infection?
Bent, S. (2002) · JAMA · doi:10.1001/jama.287.20.2701 · Cited by 549
The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy
Devillé, W. L., Yzermans, J. C., van Duijn, N. P., Bezemer, P. D., van der Windt, D. A., & Bouter, L. M. (2004) · BMC Urology · doi:10.1186/1471-2490-4-4 · Cited by 519
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Zhanel, G. G., Lawson, C. D., Adam, H., Schweizer, F., Zelenitsky, S., Lagacé-Wiens, P. R. S., Denisuik, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2013) · Drugs · doi:10.1007/s40265-013-0013-7 · Cited by 433
Global epidemiology of urinary tract infections
Tandogdu, Z., & Wagenlehner, F. M. E. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000228 · Cited by 427
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 369
Rodriguez-Bano, J., Navarro, M. D., Retamar, P., Picon, E., Pascual, A., & the Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir790 · Cited by 363
Vardakas, K. Z., Tansarli, G. S., Rafailidis, P. I., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks301 · Cited by 354
Nation, R. L., Li, J., Cars, O., Couet, W., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 354
Falagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P. I., & Tansarli, G. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-13 · Cited by 351
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Tamma, P. D., Han, J. H., Rock, C., Harris, A. D., Lautenbach, E., Hsu, A. J., Avdic, E., & Cosgrove, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ003 · Cited by 314
Pankey, G. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki248 · Cited by 301
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Prasad, P., Sun, J., Danner, R. L., & Natanson, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis270 · Cited by 298
Linhares, I., Raposo, T., Rodrigues, A., & Almeida, A. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-19 · Cited by 292
Falagas, M. E., Tansarli, G. S., Ikawa, K., & Vardakas, K. Z. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis857 · Cited by 283
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
Huttner, A., Verhaegh, E. M., Harbarth, S., Muller, A. E., Theuretzbacher, U., & Mouton, J. W. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv147 · Cited by 267
Christiaens, T. C. M., Meyere, M. D., Verschraegen, G., Peersman, W., Heytens, S., & Maeseneer, J. M. D. (2002) · Europe PMC (PubMed Central) · Cited by 260
Johansen, T. E. B., Botto, H., Cek, M., Grabe, M., Tenke, P., Wagenlehner, F. M. E., & Naber, K. G. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.009 · Cited by 222
Vazquez, J. A., González Patzán, L. D., Stricklin, D., Duttaroy, D. D., Kreidly, Z., Lipka, J., & Sable, C. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.748653 · Cited by 219
Bliziotis, I. A., Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S., & Falagas, M. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430912 · Cited by 219
Fasugba, O., Gardner, A., Mitchell, B. G., & Mnatzaganian, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1282-4 · Cited by 216
Little, P., Moore, M. V., Turner, S., Rumsby, K., Warner, G., Lowes, J. A., Smith, H., Hawke, C., Leydon, G., Arscott, A., et al. (2010) · BMJ · doi:10.1136/bmj.c199 · Cited by 210
Rooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
McLaughlin, M., Advincula, M. R., Malczynski, M., Qi, C., Bolon, M., & Scheetz, M. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00607-13 · Cited by 191
Hooton, T. M., Scholes, D., Gupta, K., Stapleton, A. E., Roberts, P. L., & Stamm, W. E. (2005) · JAMA · doi:10.1001/jama.293.8.949 · Cited by 185
Intensive care unit-acquired urinary tract infections in a regional critical care system
Laupland, K. B., Bagshaw, S. M., Gregson, D. B., Kirkpatrick, A. W., Ross, T., & Church, D. L. (2005) · Critical Care · doi:10.1186/cc3023 · Cited by 177
Sanchez, G. V., Babiker, A., Master, R. N., Luu, T., Mathur, A., & Bordon, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02897-15 · Cited by 177
Lee, N.-Y., Lee, C.-C., Huang, W.-H., Tsui, K.-C., Hsueh, P.-R., & Ko, W.-C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis916 · Cited by 175
The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
Tamma, P. D., Girdwood, S. C. T., Gopaul, R., Tekle, T., Roberts, A. A., Harris, A. D., Cosgrove, S. E., & Carroll, K. C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit395 · Cited by 172
Meier, S., Weber, R., Zbinden, R., Ruef, C., & Hasse, B. (2011) · Infection · doi:10.1007/s15010-011-0132-6 · Cited by 169
Denisuik, A. J., Lagacé-Wiens, P. R. S., Pitout, J. D. D., Mulvey, M. R., Simner, P. J., Tailor, F., Karlowsky, J. A., Hoban, D. J., Adam, H. J., Zhanel, G. G., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt027 · Cited by 163
de Jonge, B. L. M., Karlowsky, J. A., Kazmierczak, K. M., Biedenbach, D. J., Sahm, D. F., & Nichols, W. W. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03042-15 · Cited by 162
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Falagas, M. E., Vouloumanou, E. K., Togias, A. G., Karadima, M., Kapaskelis, A. M., Rafailidis, P. I., & Athanasiou, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq237 · Cited by 157
Ferry, S. A., Holm, S. E., Stenlund, H. C., Lundholm, R., & Monsen, T. (2007) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430601183074 · Cited by 155
Thaden, J. T., Fowler, V. G., Sexton, D. J., & Anderson, D. J. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.239 · Cited by 146
Briongos-Figuero, L. S., Gómez-Traveso, T., Bachiller‐Luque, P., González, M. D.-G., Gómez-Nieto, A., Palacios-Martín, T., Sagrado, M. G., Dueñas‐Laita, A., & Pérez-Castrillón, J.-L. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02991.x · Cited by 140
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Vardakas, K. Z., Legakis, N. J., Triarides, N. A., & Falagas, M. E. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.02.001 · Cited by 139
New β‐lactam–β‐lactamase inhibitor combinations in clinical development
Shlaes, D. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12010 · Cited by 130
Karlowsky, J. A., Lagacé-Wiens, P. R. S., Simner, P. J., DeCorby, M. R., Adam, H. J., Walkty, A. J., Hoban, D. J., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00066-11 · Cited by 130
Matsumura, Y., Yamamoto, M., Nagao, M., Komori, T., Fujita, N., Hayashi, A., Shimizu, T., Watanabe, H., Doi, S., Tanaka, M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-15 · Cited by 129
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
Hauck, C. G., Cober, E., Richter, S. S., Pérez, F., Salata, R. A., Kalayjian, R. C., Watkins, R., Scalera, N. M., Doi, Y., Kaye, K. S., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.023 · Cited by 125
van der Starre, W. E., van Nieuwkoop, C., Paltansing, S., Wout, J. W. V., Groeneveld, G. H., Becker, M. J., Koster, T., Wattel-Louis, G. H., Delfos, N. M., Ablij, H. C., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq465 · Cited by 123
Hoban, D. J., Lascols, C., Nicolle, L. E., Badal, R. E., Bouchillon, S. K., Hackel, M., & Hawser, S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.024 · Cited by 118
Johnson, J. R., Urban, C. M., Weissman, S. J., Jorgensen, J. H., Lewis, J. S., Hansen, G. T., Edelstein, P. H., Robicsek, A. A., Cleary, T., Adachi, J. A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05824-11 · Cited by 117
Tomas, M. E., Getman, D., Donskey, C. J., & Hecker, M. T. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00670-15 · Cited by 115
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Fralick, M., Macdonald, E. M., Gomes, T., Antoniou, T., Hollands, S., Mamdani, M. M., & Juurlink, D. N. (2014) · BMJ · doi:10.1136/bmj.g6196 · Cited by 113
Peirano, G., Richardson, D. C., Nigrin, J., McGeer, A., Loo, V. G., Toye, B., Alfa, M. J., Pienaar, C., Kibsey, P., & Pitout, J. D. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01338-09 · Cited by 113
Bouchillon, S. K., Badal, R. E., Hoban, D. J., & Hawser, S. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.022 · Cited by 111
New definitions of extended‐spectrum β‐lactamase conferring worldwide emerging antibiotic resistance
Lee, J. H., Bae, I. K., & Lee, S. H. (2010) · Medicinal Research Reviews · doi:10.1002/med.20210 · Cited by 111
Spoorenberg, V., Hulscher, M., Akkermans, R., Prins, J. M., & Geerlings, S. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit688 · Cited by 107
Paño‐Pardo, J. R., Carrascoso, G. R., Francisco, C. N.-S., Gómez-Gil, R., Mora-Rillo, M., Romero‐Gómez, M. P., Fernández-Romero, N., García‐Rodríguez, J., Pérez-Blanco, V., Moreno-Ramos, F., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks364 · Cited by 102
Buehrle, D. J., Shields, R. K., Chen, L., Hao, B., Press, E. G., Alkrouk, A., Potoski, B. A., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02969-15 · Cited by 95
Knottnerus, B. J., Geerlings, S. E., van Charante, E. P. M., & ter Riet, G. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-71 · Cited by 93
Livermore, D. M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt118 · Cited by 90
Lee, S. S., Kim, Y., & Chung, D. R. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.10.009 · Cited by 85
Sanchez, G. V., Baird, A. M. G., Karlowsky, J. A., Master, R. N., & Bordón, J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku282 · Cited by 85
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Lee, N., Lee, C., Li, C., Li, M.-C., Chen, P., Chang, C., & Ko, W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-15 · Cited by 83
Oplinger, M., & Andrews, C. O. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r352 · Cited by 79
Senol, S., Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Sipahi, H., Yamazhan, T., Arda, B., & Ulusoy, S. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.5.355 · Cited by 78
Bidell, M. R., Palchak, M., Mohr, J., & Lodise, T. P. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02505-15 · Cited by 72
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku025 · Cited by 70
Yang, Y., Ku, C., Lin, J., et al. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60031-x · Cited by 68
Marschall, J., Zhang, L., Foxman, B., Warren, D. K., & Henderson, J. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis252 · Cited by 68
Urinalysis Orders Among Patients Admitted to the General Medicine Service
Yin, P., Kiss, A., & Leis, J. A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4036 · Cited by 66
Alternatives to carbapenems in ESBL-producing Escherichia coli infections
Fournier, P., Chirouze, C., Leroy, J., Cholley, P., Talon, D. R., Plésiat, P., & Bertrand, X. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.01.006 · Cited by 66
Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Yamazhan, T., & Ulusoy, S. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.003 · Cited by 65
Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone
Antoniou, T., Hollands, S., Macdonald, E. M., Gomes, T., Mamdani, M., & Juurlink, D. N. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.140816 · Cited by 65
Ducharme, J., Neilson, S., & Ginn, J. L. (2007) · Canadian Journal of Emergency Medicine · doi:10.1017/s1481803500014846 · Cited by 64
Cprek, J. B., & Gallagher, J. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-15 · Cited by 63
Huntington, J. A., Sakoulas, G., Umeh, O., Cloutier, D. J., Steenbergen, J. N., Bliss, C. A., & Goldstein, E. J. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw053 · Cited by 60
Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance
Sastry, S., Clarke, L. G., Alrowais, H., Querry, A. M., Shutt, K. A., & Doi, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01071-15 · Cited by 57
Veve, M. P., Wagner, J. L., Kenney, R. M., Grunwald, J. L., & Davis, S. L. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.014 · Cited by 55
Castanheira, M., Mendes, R. E., Jones, R. N., & Sader, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00540-16 · Cited by 55
Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women
Singh, N., Gandhi, S., McArthur, E., MOIST, L. M., Jain, A. K., Liu, A. R., Sood, M. M., & Garg, A. X. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150067 · Cited by 52
Karlowsky, J. A., Denisuik, A. J., Lagacé-Wiens, P. R. S., Adam, H. J., Baxter, M. R., Hoban, D. J., & Zhanel, G. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02399-13 · Cited by 50
Geerts, A. F. J., Eppenga, W. L., Heerdink, E. R., Derijks, H. J., Wensing, M., Egberts, T. C. G., & Smet, P. A. G. M. D. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1520-x · Cited by 50
Koningstein, M., van der Bij, A. K., de Kraker, M. E. A., Monen, J., Muilwijk, J., de Greeff, S. C., Geerlings, S. E., van Hall, M. A. L., & on behalf of the ISIS-AR Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0086634 · Cited by 47
Morrow, B. J., Pillar, C. M., Deane, J., Sahm, D. F., Lynch, A. S., Flamm, R. K., Peterson, J., & Davies, T. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.012 · Cited by 46
Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
Grossman, T. H., Murphy, T. M., Slee, A., Lofland, D., & Sutcliffe, J. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04354-14 · Cited by 45
Linsenmeyer, K. D., Strymish, J. M., & Gupta, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-15 · Cited by 45
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics
Hirsch, E. B., Zucchi, P., Chen, A., Raux, B. R., Kirby, J. E., McCoy, C. P., & Eliopoulos, G. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02961-15 · Cited by 42
Titelman, E., Iversen, A., Kalin, M., & Giske, C. G. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0161 · Cited by 41
Rodríguez‐Baño, J., Mingorance, J., Fernández-Romero, N., Serrano, L., López‐Cerero, L., Pascual, Á., & the ESBL-REIPI group (2012) · PLoS ONE · doi:10.1371/journal.pone.0044238 · Cited by 40
İpekçi, T., Seyman, D., Berk, H., & Çelik, O. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.08.007 · Cited by 40
Shilo, S., Assous, M. V., Lachish, T., Kopuit, P., Bdolah‐Abram, T., Yinnon, A. M., & Weil‐Weiner, Y. (2012) · Infection · doi:10.1007/s15010-012-0380-0 · Cited by 38
Lee, C.-H., Lee, Y., Kung, C.-H., Ku, W.-W., Kuo, S., Chen, T.-L., & Fung, C. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.08.010 · Cited by 34
Peterson, J., Kaul, S., Khashab, M. A., Fisher, A. C., & Kahn, J. B. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.10.008 · Cited by 32
No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis
Cobussen, M., de Kort, J. M. L., Dennert, R. M., Lowe, S. H., & Stassen, P. M. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1109136 · Cited by 32
Sader, H. S., Castanheira, M., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-16 · Cited by 30
Mendes, R. E., Castanheira, M., Gasink, L. B., Stone, G. G., Nichols, W. W., Flamm, R. K., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01173-15 · Cited by 27
Blanchette, L. M., Kuti, J. L., Nicolau, D. P., et al. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.954262 · Cited by 24
Ironmonger, D., Edeghere, O., Gossain, S., & Hawkey, P. M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1559-2 · Cited by 19
Daley, P., Penney, C., Wakeham, S., Compton, G., McKim, A., O’Keefe, J., Barrett, B. J., & Nicolle, L. E. (2015) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2015/830415 · Cited by 15
Pilmis, B., Delory, T., Groh, M., et al. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.08.011 · Cited by 13
Tambyah, P. A., Hara, G. L., Daikos, G. L., Falagas, M. E., Mazzei, T., Mouton, J. W., Novelli, A., Chen, B., Wang, M., Ko, W., et al. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.04.002 · Cited by 7
Cited by
Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., Eckert, L. O., Geerlings, S. E., Köves, B., Hooton, T. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz021 · Cited by 737
Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., Eckert, L. O., Geerlings, S. E., Köves, B., Hooton, T. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1121 · Cited by 559
Urinary Tract Infections: The Current Scenario and Future Prospects
Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., & Biondo, C. (2023) · Pathogens · doi:10.3390/pathogens12040623 · Cited by 396
European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines
Kranz, J., Bartoletti, R., Bruyère, F., Cai, T., Geerlings, S., Köves, B., Schubert, S., Pilatz, A., Veeratterapillay, R., Wagenlehner, F. M. E., et al. (2024) · European Urology · doi:10.1016/j.eururo.2024.03.035 · Cited by 340
Zhou, Y., Zhou, Z., Zheng, L., Gong, Z., Li, Y., Jin, Y., Huang, Y., & Chi, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310537 · Cited by 305
Metadata
- Authors
- Bader, M. S., Loeb, M., & Brooks, A. A.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2016-10-21
- Volume
- 129
- Issue
- 2
- Pages
- 242-258
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W2528299860
- Cited by
- 261
- References
- 116
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.